Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02034110 |
| Title | Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | GlaxoSmithKline |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | SWE | NOR | NLD | ITA | FRA | ESP | DNK | DEU | CAN | BEL | AUT |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Novartis Investigative Site | Little Rock | Arkansas | 72205 | United States | Details | |
| Novartis Investigative Site | Santa Monica | California | 90404 | United States | Details | |
| Novartis Investigative Site | Bethesda | Maryland | 20892 | United States | Details | |
| Novartis Investigative Site | Boston | Massachusetts | 02114 | United States | Details | |
| Novartis Investigative Site | Boston | Massachusetts | 02215 | United States | Details | |
| Novartis Investigative Site | New York | New York | 10016 | United States | Details | |
| Novartis Investigative Site | Nashville | Tennessee | 37203 | United States | Details | |
| Novartis Investigative Site | Houston | Texas | 77030 | United States | Details | |
| Novartis Investigative Site | Innsbruck | 6020 | Austria | Details | ||
| Novartis Investigative Site | Linz | 4020 | Austria | Details | ||
| Novartis Investigative Site | Salzburg | 5020 | Austria | Details | ||
| Novartis Investigative Site | Wien | 1090 | Austria | Details | ||
| Novartis Investigative Site | Jette | 1090 | Belgium | Details | ||
| Novartis Investigative Site | Toronto | Ontario | M5G 2M9 | Canada | Details | |
| Novartis Investigative Site | Copenhagen | 2100 | Denmark | Details | ||
| Novartis Investigative Site | Bordeaux Cedex | 33076 | France | Details | ||
| Novartis Investigative Site | Lyon Cedex 08 | 69373 | France | Details | ||
| Novartis Investigative Site | Nantes cedex 1 | 44093 | France | Details | ||
| Novartis Investigative Site | Saint-Herblain Cedex | 44805 | France | Details | ||
| Novartis Investigative Site | Toulouse Cedex 9 | 31059 | France | Details | ||
| Novartis Investigative Site | Villejuif Cedex | 94805 | France | Details | ||
| Novartis Investigative Site | Freiburg | Baden-Wuerttemberg | 79106 | Germany | Details | |
| Novartis Investigative Site | Heidelberg | Baden-Wuerttemberg | 69120 | Germany | Details | |
| Novartis Investigative Site | Mannheim | Baden-Wuerttemberg | 68167 | Germany | Details | |
| Novartis Investigative Site | Berlin | 13353 | Germany | Details | ||
| Novartis Investigative Site | Hamburg | 20246 | Germany | Details | ||
| Novartis Investigative Site | Milano | Lombardia | 20132 | Italy | Details | |
| Novartis Investigative Site | Milano | Lombardia | 20133 | Italy | Details | |
| Novartis Investigative Site | Milano | Lombardia | 20141 | Italy | Details | |
| Novartis Investigative Site | Chiba | 277-8577 | Japan | Details | ||
| Novartis Investigative Site | Tokyo | 104-0045 | Japan | Details | ||
| Novartis Investigative Site | Seoul | 03080 | Korea, Republic of | Details | ||
| Novartis Investigative Site | Seoul | 06273 | Korea, Republic of | Details | ||
| Novartis Investigative Site | Amsterdam | 1066 CX | Netherlands | Details | ||
| Novartis Investigative Site | Amsterdam | 1081 HV | Netherlands | Details | ||
| Novartis Investigative Site | Rotterdam | 3015 GD | Netherlands | Details | ||
| Novartis Investigative Site | Utrecht | 3584 CX | Netherlands | Details | ||
| Novartis Investigative Site | Oslo | 0310 | Norway | Details | ||
| Novartis Investigative Site | Barcelona | 08035 | Spain | Details | ||
| Novartis Investigative Site | Madrid | 28041 | Spain | Details | ||
| Novartis Investigative Site | Stockholm | 171 76 | Sweden | Details |